US 11648211
Nanoencapsulated combination drug formulations
granted A61KA61K31/5025A61K31/519
Quick answer
US patent 11648211 (Nanoencapsulated combination drug formulations) held by Northwestern University expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/5025, A61K31/519, A61K45/06, A61K9/10